Literature DB >> 10049450

Risk of cancer in ulcerative colitis.

B Levin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049450     DOI: 10.1016/s0016-5107(99)70527-4

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  7 in total

Review 1.  Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosis.

Authors:  M J Bruno
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

Review 2.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications.

Authors:  Kathryn T Baker; Jesse J Salk; Teresa A Brentnall; Rosa Ana Risques
Journal:  Carcinogenesis       Date:  2018-01-12       Impact factor: 4.944

3.  In vivo detection of experimental ulcerative colitis in rats using fiberoptic confocal imaging (FOCI).

Authors:  W McLaren; P Anikijenko; D Barkla; T P Delaney; R King
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

Review 4.  Incidence and management of colorectal cancer in liver transplant recipients.

Authors:  Taiga Nishihori; Mario Strazzabosco; Muhammad Wasif Saif
Journal:  Clin Colorectal Cancer       Date:  2008-07       Impact factor: 4.481

5.  Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.

Authors:  Davy Carlos Mendes Rapozo; Ana Braunstein Grinmann; Ana Teresa Pugas Carvalho; Heitor Siffert P de Souza; Sheila Coelho Soares-Lima; Tatiana de Almeida Simão; Daurita de Paiva; Flávio Abby; Rodolpho Mattos Albano; Luiz Felipe Ribeiro Pinto
Journal:  Int J Colorectal Dis       Date:  2009-06-20       Impact factor: 2.571

Review 6.  Clinical management of inflammatory bowel disease in the organ recipient.

Authors:  Amedeo Indriolo; Paolo Ravelli
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

7.  Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation.

Authors:  H Messmann; E Endlicher; G Freunek; P Rümmele; J Schölmerich; R Knüchel
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.